These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11696471)

  • 21. Self-management of oral anticoagulation therapy--methodological and clinical aspects.
    Christensen TD
    Dan Med Bull; 2011 May; 58(5):B4284. PubMed ID: 21535992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interpreting the International Normalized Ratio (INR) in individuals receiving argatroban and warfarin.
    Sheth SB; DiCicco RA; Hursting MJ; Montague T; Jorkasky DK
    Thromb Haemost; 2001 Mar; 85(3):435-40. PubMed ID: 11307810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
    Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
    Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of oral diuretics on chronic warfarin therapy: a retrospective study.
    Edwards HD; Webb RD; Conway SE
    Expert Opin Drug Saf; 2012 May; 11(3):375-80. PubMed ID: 21957964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring anticoagulation in patients with an unreliable prothrombin time/international normalized ratio: factor II versus chromogenic factor X testing.
    Baumann Kreuziger LM; Datta YH; Johnson AD; Zantek ND; Shanley R; Reding MT
    Blood Coagul Fibrinolysis; 2014 Apr; 25(3):232-6. PubMed ID: 24681704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombin generation and factor X assays for the assessment of warfarin anticoagulation in thrombotic antiphospholipid syndrome.
    Efthymiou M; Lawrie AS; Mackie I; Arachchillage D; Lane PJ; Machin S; Cohen H
    Thromb Res; 2015 Jun; 135(6):1191-7. PubMed ID: 25895847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Switching from acenocoumarol to warfarin in patients with unstable anticoagulation and its effect on anticoagulation control.
    Undas A; Cieśla-Dul M; Zółciński M; Tracz W
    Pol Arch Med Wewn; 2009 Jun; 119(6):360-5. PubMed ID: 19694217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent venous thrombosis despite 'optimal anticoagulation therapy' for antiphospholipid syndrome--could new oral anticoagulants solve the problem?
    Balaban M; Stanrić V; Rincić G; Ledinsky M; Grbac L; Stancić N; Tomasić H
    Acta Clin Croat; 2010 Dec; 49(4):469-77. PubMed ID: 21830460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram: do we really need genotyping?
    Le Gal G; Carrier M; Tierney S; Majeed H; Rodger M; Wells PS
    J Thromb Haemost; 2010 Jan; 8(1):90-4. PubMed ID: 19874475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring warfarin therapy in patients with lupus anticoagulants.
    Moll S; Ortel TL
    Ann Intern Med; 1997 Aug; 127(3):177-85. PubMed ID: 9245222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ex vivo thrombin generation in patients with venous thromboembolic disease or atrial fibrillation on long-term oral anticoagulation.
    Musial J; Brzezinska-Kolarz B; Zólcinski M; Lelakowski J; Szczeklik A
    Clin Appl Thromb Hemost; 2010 Dec; 16(6):614-21. PubMed ID: 20460350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of warfarin knowledge on anticoagulation control among patients with heart valve replacement.
    Cao H; Wu T; Chen W; Fu J; Xia X; Zhang J
    Int J Clin Pharm; 2020 Jun; 42(3):861-870. PubMed ID: 32410208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms in VKORC1 have more impact than CYP2C9 polymorphisms on early warfarin International Normalized Ratio control and bleeding rates.
    Lund K; Gaffney D; Spooner R; Etherington AM; Tansey P; Tait RC
    Br J Haematol; 2012 Jul; 158(2):256-261. PubMed ID: 22571356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial.
    Dignan R; Keech AC; Gebski VJ; Mann KP; Hughes CF;
    Int J Cardiol; 2013 Oct; 168(6):5378-84. PubMed ID: 24083884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality control of oral anticoagulation with vitamin K antagonists in primary care patients in Poland: a multi-centre study.
    Sawicka-Powierza J; Buczkowski K; Chlabicz S; Gugnowski Z; Powierza K; Ołtarzewska AM
    Kardiol Pol; 2018; 76(4):764-769. PubMed ID: 29313558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
    Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defining time in therapeutic range for busy clinicians: frequency of dose changes is a good surrogate marker to identify patients with suboptimal anticoagulation with warfarin.
    Vijenthira A; Le Gal G; Castellucci LA; Carrier M
    Thromb Res; 2014 Sep; 134(3):584-6. PubMed ID: 25037497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
    Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
    J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate.
    Deveras RA; Kessler CM
    Ann Intern Med; 2002 Dec; 137(11):884-8. PubMed ID: 12458988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.